Alendronate Induces Antinociception in Mice, Not Related With Its Effects in Bone
Open Access
- 1 January 1999
- journal article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 79 (4) , 433-437
- https://doi.org/10.1254/jjp.79.433
Abstract
The antinociceptive effect of alendronate was studied. The bisphosphonate was i.p. administered and two tests were carried out: acetic acid in mice and formalin test in rats. In the acetic acid test, alendronate induced a dose-dependent antinociceptive effect that was statistically significant for the doses of 10, 20 and 40 mg/kg, and could be detected 48 hr after its administration. In the formalin test, however, alendronate, at the doses of 10 and 20 mg/kg, did not modify the pain score nor the number of flinches, when it was administered either 30 or 60 min before the test. However it must be noted that doses inducing analgesic effect are close to those inducing toxicity.Keywords
This publication has 14 references indexed in Scilit:
- Effects of Alendronate on Gastric and Duodenal MucosaAmerican Journal of Gastroenterology, 1998
- Bisphosphonates in prostate carcinomaCancer, 1997
- Bisphosphonate therapy of reflex sympathetic dystrophy syndromeAnnals of the Rheumatic Diseases, 1997
- Bisphosphonates for controlling pain from metastatic bone diseaseAmerican Journal of Health-System Pharmacy, 1996
- Pain Killing with Calcitonin Nasal Spray in Patients with Malignant TumorsOncology, 1992
- Calcitonin in phantom limb pain: a double-blind studyPain, 1992
- BisphosphonatesDrugs, 1991
- Intermittent Cyclical Etidronate Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- New Diphosphonates to Block Bone ResorptionNew England Journal of Medicine, 1980
- EFFECTS OF DISODIUM DICHLOROMETHYLENE DIPHOSPHONATE ON PAGET'S DISEASE OF BONEThe Lancet, 1979